Project

A Phase 1, dose-finding study of Debio 0123 as monotherapy in adult patients with advanced solid tumors, followed by an expansion part to assess safety and preliminary anti-tumor activity

Ongoing - recruitment active · 2024 until 2099

Hess Dagmar, Scherrer Julia, Quinter Janine